OVERVIEW

Now in its 21st year, and presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. The course will critically review current treatment options. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis.

TARGET AUDIENCE

The course will provide an update on current recommendations about screening and treatment of osteoporosis for physicians and other clinicians working with osteoporosis patients. It will also benefit researchers, technologists, and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. No prior clinical or scientific training in osteoporosis is required.

Live Stream Meeting
This course will be offered as a virtual conference. Login instructions along with the digital syllabus will be shared with the attendees a week before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.

LEARNING OBJECTIVES

• Screen for and diagnose osteoporosis according to the latest evidence-based standards of care;
• Interpret dual-energy X-ray absorptiometry (DXA) bone density scans and avoid common DXA pitfalls;
• Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies;
• Assess the benefits and risks of continuing long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
• Understand the evidence for vitamin D in the optimization of bone health;
• Recognize racial differences and disparities in osteoporosis care.

ACCREDIATION

In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

UCSF has approved this program for CME credit: UCSF designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.